Reported in Nature Biomedical Engineering, the system combines a magnetically responsive body with a flexible carpet of artificial cilia. The magnetic component allows clinicians to guide the robot through the vascular system and position it near an occluded or narrowed branch. Once it reaches its target, the cilia generate coordinated metachronal waves—traveling patterns of motion similar to those used by biological cilia—to propel surrounding fluid. This separates navigation from flow control, enabling the device to move into place first and then enhance circulation locally without requiring continuous movement of the entire robot.

The distinction is important because conventional endovascular tools generally focus on mechanical intervention. Catheters, guidewires and stents can restore a pathway or deliver a therapeutic agent, but they do not necessarily recreate the flow conditions required for efficient transport. Pharmacological treatments face a similar limitation. A drug introduced upstream may be diluted, diverted through neighboring branches or unable to penetrate stagnant blood beyond an obstruction. By producing fluid motion directly at the diseased site, the soft robot is intended to improve the exchange of blood and therapeutic compounds while reducing dependence on naturally restored circulation.

At the center of the device is its cilia carpet, a flexible structure whose individual elements are actuated by magnetic forces. When the cilia move with carefully timed differences in phase, they create a metachronal wave that travels across the surface. This coordinated motion produces a net pumping effect, even though each individual cilium may oscillate back and forth rather than rotate continuously. The mechanism resembles the transport strategy found in microscopic biological systems, where arrays of cilia move mucus, reproductive fluids or other liquids. In the robot, the same principle is adapted to the confined geometry and demanding flow conditions of blood vessels.

The researchers investigated how the geometry and arrangement of the cilia influence performance. Parameters such as cilium dimensions, spacing, flexibility and the timing of their motion determine how effectively mechanical movement is converted into fluid transport. These factors are especially consequential inside vessels, where the robot must operate in a narrow channel and interact with a viscous, biologically complex liquid. The study examined the flow-regulation mechanism and optimized the structure of the cilia carpet to produce useful circulation without relying on the robot’s physical relocation.

Tests in vessel phantoms were used to evaluate the system under conditions intended to reflect biological environments. Such models allow investigators to control vessel diameter, obstruction geometry, fluid viscosity and flow rate while observing how the robot alters transport around a blockage. The reported experiments showed that the device could regulate flow in different vascular configurations, including situations in which an occlusion obstructed a branch. These tests provided a controlled setting for examining whether the cilia-generated motion could move fluid beyond an obstruction and improve the distribution of agents delivered through the model vessel.

The researchers also assessed the robot’s potential for drug-assisted clot removal. Thrombolytic therapies work by breaking down the protein framework that stabilizes a blood clot, but their effectiveness can be limited when the drug does not reach the clot uniformly or remains in contact with it for too short a time. Local flow enhancement could improve the delivery of the therapeutic agent to the clot surface and promote the exchange of treated and untreated fluid. In the reported experiments, the combination of active flow regulation and drug treatment accelerated clot dissolution, reduced residual obstruction and shortened the time required for recanalization compared with treatment approaches lacking the robot’s pumping action.

The system was further evaluated in large-animal studies, an important step because blood vessels in living organisms introduce factors that are difficult to reproduce in laboratory models. Pulsatile flow, vessel compliance, branching anatomy and interactions with blood cells can all influence the behavior of an endovascular device. According to the study, the robot restored flow in occluded branches and improved the delivery of therapeutic agents in vivo. The results suggest that the approach can operate within a realistic vascular environment while maintaining its two separate functions: magnetic navigation to the target and cilia-based regulation after deployment.

The device’s soft construction may offer advantages in a setting where rigid instruments can damage delicate vessel walls or struggle to adapt to changing anatomy. Its small scale and flexible components are intended to support movement through complex vascular pathways, while magnetic control provides a means of steering from outside the body. At the same time, the approach introduces challenges that will need to be addressed before clinical use. Any endovascular robot must be compatible with imaging and clinical navigation systems, avoid obstructing the vessel, withstand repeated actuation and operate safely in the presence of blood components. The forces generated by the cilia must also be strong enough to improve transport without causing unwanted damage or disturbing unstable clot material.

The study presents the robot as a platform for active, localized vascular therapy rather than as a replacement for existing interventions. Its most significant feature is the ability to modulate flow after arriving at a target site. That capability could be relevant not only to clot dissolution but also to other treatments in which local transport is a limiting factor, including targeted drug delivery and therapies for diseased or poorly perfused vessels. By turning a miniature endovascular device into both a navigation tool and a local fluid regulator, the researchers aim to make vascular treatment more controllable. The findings point toward a future in which robotic systems do more than reach an obstruction: they could reshape the microscopic flow environment around it to help medicines work more efficiently.

Subject of Research: A miniature endovascular soft robot that uses magnetically controlled navigation and cilia-generated metachronal waves to regulate blood flow and improve drug transport in occluded vessels.

Article Title: A miniature endovascular soft robot for active blood flow regulation in occluded vessels

Article References: Fang, K., Wang, Y., Liang, J. et al. “A miniature endovascular soft robot for active blood flow regulation in occluded vessels.” Nature Biomedical Engineering (2026). https://doi.org/10.1038/s41551-026-01771-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41551-026-01771-y

Keywords: endovascular soft robot, blood flow regulation, magnetic navigation, artificial cilia, metachronal waves, drug delivery, clot dissolution, vascular occlusion, thrombolysis, biomedical robotics

The genesis of this technology lies in biomimicry, drawing inspiration from the elegant and adaptive foraging behaviors of fish schools in the wild. Fish often increase their chances of survival and search efficiencies by dynamically aggregating and dispersing in response to environmental cues. Mirroring this phenomenon, the researchers have designed each robot to emulate the swimming mechanics and social coordination of fish, allowing the swarm to collectively navigate, explore, and interact with targeted tissue sites in the human body.

Each individual robotic unit is composed of hard-magnetic elastomers, materials that exhibit both compliance and magneto-responsive properties. This unique composition enables the soft robots to respond precisely to externally applied magnetic fields. With actuation driven by an oscillating magnetic field supplemented by a gradient field, these robots can manifest complex swimming behaviors with six degrees of freedom: pitch, yaw, roll, horizontal and vertical translation, and forward propulsion. These movement capabilities grant the robots an extraordinary level of maneuverability, akin to swimming fish, permitting their penetration into intricate and confined biological regions.

A pivotal breakthrough reported by the team involves the meticulous programming of the magnetic field’s constant component at frequencies close to the robots’ natural resonance. It is within this resonance regime that the swimming direction of the robots is dominantly governed by this constant field component. Exploiting this principle, the researchers successfully induce selective directional control within the swarm, causing individual robots to swim independently along divergent trajectories despite the application of a uniform global magnetic field. This differential regulation constitutes a significant leap toward genuinely coordinated swarm control under a single overarching magnetic actuation system.

Such precision control permits the robotic swarm to dynamically disperse to navigate constricted anatomical pathways or to aggregate upon reaching pathological sites, such as lesions or tumors. Notably, once the swarm arrives at the lesion interface, the robots collectively adjust their configuration and morphology to conform to the solid-liquid interface of the diseased tissue. This adaptive shape modulation not only enhances adhesion to the target site but also optimizes the coverage area for drug dispensing, maximizing therapeutic efficacy while minimizing off-target side effects.

In rigorous laboratory and ex vivo trials employing animal tissue models, the team demonstrated the feasibility and efficacy of this approach. One compelling experiment showcased how the robot swarm adeptly navigated toward a synthetic gastric lesion. Upon congregating at the lesion, the swarm reconfigured itself to align precisely with the lesion’s contours, positioning itself optimally for targeted drug administration. These results underscore the potential clinical relevance of the technology for site-specific therapy in gastrointestinal maladies.

The implications of utilizing soft magnetic materials are profound. Their intrinsic flexibility ensures biocompatibility and reduces potential tissue damage during navigation. Moreover, their responsiveness to remotely controlled magnetic fields obviates the need for onboard power sources or complex control electronics within each robot, drastically simplifying miniaturization and enhancing systemic safety.

The research team meticulously characterized the dynamic interplay between the oscillating magnetic fields and the robots’ resonant behaviors. By harnessing the natural frequency of the robots’ oscillatory motions, they unlocked highly selective directional control, a breakthrough unmatched in prior miniature soft robotic designs. This innovative control methodology underpins the swarm’s autonomous yet coordinated movement.

Moreover, the ability of the swarm to exhibit collective decision-making behaviors, such as obstacle avoidance and environmental adaptation, mirrors biological ecosystems, further enhancing their utility in unpredictable in vivo environments. The robots’ capacity to adjust their swarm morphology provides versatility in addressing lesions of various shapes, sizes, and textures.

Funding for this pioneering research was provided by the National Key Research and Development Program of China, the National Natural Science Foundation of China, and the Natural Science Foundation of Heilongjiang Province. This collaborative investment highlights the strategic importance of advancing soft robotics for biomedical applications.

Looking ahead, this multifaceted robotic swarm platform opens diverse avenues for minimally invasive diagnostics, therapeutic interventions, and postoperative monitoring. Its scalability, responsiveness, and adaptive capabilities position it as a front-runner for clinical translation, particularly in treating diseases where precision matters, such as cancer and localized infections.

As the global scientific community continues to explore the frontiers of microrobotics and bioinspired engineering, the Harbin team’s work stands as a testament to the power of interdisciplinary innovation. By fusing materials science, fluid dynamics, magnetic field engineering, and bioautomation, they have charted a path toward smarter, safer, and more effective medical interventions with swarms of fish-like soft robots leading the charge.

Subject of Research: Miniature fish-like magnetic soft robot swarms for targeted drug delivery via resonance-based magnetic field control.

Article Title: Not provided in the content.

News Publication Date: Not provided in the content.

Web References:
http://dx.doi.org/10.1093/nsr/nwaf429

References: Not explicitly provided.

Image Credits: ©Science China Press

Keywords

Miniature robots, magnetic soft robotics, swarm robotics, targeted drug delivery, biomedical engineering, magnetic field control, six degrees of freedom, resonance frequency, biomimicry, robotic navigation, lesion targeting, adaptive morphology, fish-inspired robotics.